4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-CYCLOPENTYL-PYRIDINE-2-CARBOXAMIDE
Compound with spectra: 1 NMR
![4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-CYCLOPENTYL-PYRIDINE-2-CARBOXAMIDE](/api/compound/HFhXe9SZ33V.png?ph=true&h=300&w=458 "4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-CYCLOPENTYL-PYRIDINE-2-CARBOXAMIDE")
| SpectraBase Compound ID | HFhXe9SZ33V |
|---|---|
| InChI | InChI=1S/C25H22ClF3N4O3/c26-21-10-7-17(13-20(21)25(27,28)29)33-24(35)32-16-5-8-18(9-6-16)36-19-11-12-30-22(14-19)23(34)31-15-3-1-2-4-15/h5-15H,1-4H2,(H,31,34)(H2,32,33,35) |
| InChIKey | XAWBOEGQDBWRRK-UHFFFAOYSA-N |
| Mol Weight | 518.92 g/mol |
| Molecular Formula | C25H22ClF3N4O3 |
| Exact Mass | 518.133253 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-CYCLOHEXYL-PYRIDINE-2-CARBOXAMIDE
4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-PHENYLETHYL-PYRIDINE-2-CARBOXAMIDE
4-[4-[[4-CHLORO-3-(TRIFLUOROMETHY)-PHENYL]-CARBAMOYLAMINO]-PHENOXY]-N-BENZYL-PYRIDINE-2-CARBOXAMIDE
N-[4-chloro-3-(trifluoromethyl)phenyl]-3-(4-methoxyphenyl)-4,5-dihydro-5-isoxazolecarboxamide
benzamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-3-(1H-tetrazol-1-yl)-
1-(4-chlorophenyl)-N-[4-chloro-3-(trifluoromethyl)phenyl]-5-oxo-3-pyrrolidinecarboxamide
2-[(6-bromo-3H-imidazo[4,5-b]pyridin-2-yl)sulfanyl]-N-[4-chloro-3-(trifluoromethyl)phenyl]acetamide
N-[4-chloro-3-(trifluoromethyl)phenyl]-1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-piperidinecarboxamide
3-pyridinecarboxamide, N-[4-(4-cyclohexylphenoxy)-3-(trifluoromethyl)phenyl]-
1-{6-[(4-CHLORO-3,5-XYLYL)OXY]-alpha,alpha,alpha-TRIFLUORO-m-TOLYL}-3-(TRICHLOROVINYL)UREA
| Title | Journal or Book | Year |
|---|---|---|
| New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation | Molecules | 2012 |